Literature DB >> 18669975

Treatment of pediatric acute lymphoblastic leukemia.

Fabio Tucci, Maurizio Aricò.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18669975     DOI: 10.3324/haematol.13517

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  6 in total

1.  Bridging the gap between the north and south of the world: the case of treatment response in childhood acute lymphoblastic leukemia.

Authors:  Martin Stanulla; André Schrauder
Journal:  Haematologica       Date:  2009-06       Impact factor: 9.941

2.  New flow cytometry in hematologic malignancies.

Authors:  Jan Cools; Peter Vandenberghe
Journal:  Haematologica       Date:  2009-12       Impact factor: 9.941

3.  End of induction minimal residual disease alone is not a useful determinant for risk stratified therapy in pediatric T-cell acute lymphoblastic leukemia.

Authors:  Chintan Parekh; Paul S Gaynon; Hisham Abdel-Azim
Journal:  Pediatr Blood Cancer       Date:  2015-05-14       Impact factor: 3.167

4.  Low platelet counts after induction therapy for childhood acute lymphoblastic leukemia are strongly associated with poor early response to treatment as measured by minimal residual disease and are prognostic for treatment outcome.

Authors:  Lutz Zeidler; Martin Zimmermann; Anja Möricke; Barbara Meissner; Dorothee Bartels; Christoph Tschan; André Schrauder; Gunnar Cario; Lilia Goudeva; Sarah Jäger; Richard Ratei; Wolf-Dieter Ludwig; Andrea Teigler-Schlegel; Julia Skokowa; Rolf Koehler; Claus R Bartram; Hansjörg Riehm; Martin Schrappe; Karl Welte; Martin Stanulla
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

5.  Compliance with a protocol for acute lymphoblastic leukemia in childhood.

Authors:  Benigna Maria de Oliveira; Maria Thereza Macedo Valadares; Marcilene Rezende Silva; Marcos Borato Viana
Journal:  Rev Bras Hematol Hemoter       Date:  2011

6.  Magnetic resonance imaging of the brain in survivors of childhood acute lymphoblastic leukemia.

Authors:  Mohamed Ahmed Badr; Tamer Hasan Hassan; Khaled Mohamed El-Gerby; Mohamed El-Sayed Lamey
Journal:  Oncol Lett       Date:  2012-12-12       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.